3 Profitable Stocks We Approach with Caution

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Not all profitable companies are created equal, and that’s why we built StockStory - to help you find the ones that truly shine bright. That said, here are three profitable companies to steer clear of and a few better alternatives.

Installed Building Products (IBP)

Trailing 12-Month GAAP Operating Margin: 12.5%

Founded in 1977, Installed Building Products (NYSE:IBP) is a company specializing in the installation of insulation, waterproofing, and other complementary building products for residential and commercial construction.

Why Does IBP Worry Us?

1. 3.5% annual revenue growth over the last two years was slower than its industrials peers
2. Sales are projected to tank by 3.1% over the next 12 months as demand evaporates
3. Earnings per share lagged its peers over the last two years as they only grew by 5.3% annually

Installed Building Products is trading at $263.71 per share, or 26.4x forward P/E. Check out our free in-depth research report to learn more about why IBP doesn’t pass our bar.

Select Medical (SEM)

Trailing 12-Month GAAP Operating Margin: 6.3%

With a nationwide network spanning 46 states and over 2,700 healthcare facilities, Select Medical (NYSE:SEM) operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers across the United States.

Why Is SEM Risky?

1. Declining admissions over the past two years suggest it might have to lower prices to accelerate growth
2. Forecasted revenue decline of 4.5% for the upcoming 12 months implies demand will fall even further
3. Performance over the past five years shows its incremental sales were much less profitable, as its earnings per share fell by 3.4% annually

Select Medical’s stock price of $12.87 implies a valuation ratio of 10.8x forward P/E. If you’re considering SEM for your portfolio, see our FREE research report to learn more.

U.S. Physical Therapy (USPH)

Trailing 12-Month GAAP Operating Margin: 10.1%

With a nationwide footprint spanning 671 clinics across 42 states, U.S. Physical Therapy (NYSE:USPH) operates a network of outpatient physical therapy clinics and provides industrial injury prevention services to employers across the United States.

Why Do We Think Twice About USPH?

1. Modest revenue base of $729.6 million gives it less fixed cost leverage and fewer distribution channels than larger companies
2. Free cash flow margin dropped by 9 percentage points over the last five years, implying the company became more capital intensive as competition picked up
3. Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability

At $80.15 per share, U.S. Physical Therapy trades at 30.9x forward P/E. Read our free research report to see why you should think twice about including USPH in your portfolio.

High-Quality Stocks for All Market Conditions

Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.

The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.